Detalles de la búsqueda
1.
BIOSOLVE-IV-registry: Safety and performance of the Magmaris scaffold: 12-month outcomes of the first cohort of 1,075 patients.
Catheter Cardiovasc Interv
; 98(1): E1-E8, 2021 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32881396
2.
Blinded outcomes and angina assessment of coronary bioresorbable scaffolds: 30-day and 1-year results from the ABSORB IV randomised trial.
Lancet
; 392(10157): 1530-1540, 2018 10 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-30266412
3.
The analysis of microRNA expression profiling for coronary artery disease.
Cardiology
; 127(1): 62-9, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24247647
4.
C-reactive protein in human atherogenesis: facts and fiction.
Mediators Inflamm
; 2014: 561428, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24799767
5.
Temporal changes in coronary plaque as assessed by an artificial intelligence-based optical coherence tomography: from the first-in-human trial on DREAMS 3G scaffold.
Eur Heart J Cardiovasc Imaging
; 25(4): 491-497, 2024 Mar 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37936296
6.
One- and two-year clinical outcomes of treatment with resorbable magnesium scaffolds for coronary artery disease: the prospective, international, multicentre BIOSOLVE-IV registry.
EuroIntervention
; 19(3): 232-239, 2023 Jun 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-37226676
7.
Imaging Predictors of Left Ventricular Functional Recovery after Reperfusion Therapy of ST-Elevation Myocardial Infarction Assessed by Cardiac Magnetic Resonance.
J Cardiovasc Dev Dis
; 10(7)2023 Jul 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37504550
8.
Safety and performance of the third-generation drug-eluting resorbable coronary magnesium scaffold system in the treatment of subjects with de novo coronary artery lesions: 6-month results of the prospective, multicenter BIOMAG-I first-in-human study.
EClinicalMedicine
; 59: 101940, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37113674
9.
A new resorbable magnesium scaffold for de novo coronary lesions (DREAMS 3): one-year results of the BIOMAG-I first-in-human study.
EuroIntervention
; 19(5): e414-e422, 2023 Aug 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37334655
10.
5-Year Outcomes After Bioresorbable Coronary Scaffolds Implanted With Improved Technique.
J Am Coll Cardiol
; 82(3): 183-195, 2023 07 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37207924
11.
Cardiac Glycosides Lower C-Reactive Protein Plasma Levels in Patients with Decompensated Heart Failure: Results from the Single-Center C-Reactive Protein-Digoxin Observational Study (C-DOS).
J Clin Med
; 11(7)2022 Mar 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-35407370
12.
Targeting C-Reactive Protein by Selective Apheresis in Humans: Pros and Cons.
J Clin Med
; 11(7)2022 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-35407379
13.
A Report on the First 7 Sequential Patients Treated Within the C-Reactive Protein Apheresis in COVID (CACOV) Registry.
Am J Case Rep
; 23: e935263, 2022 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35007274
14.
Sustainability of C-Reactive Protein Apheresis in Acute Myocardial Infarction-Results from a Supplementary Data Analysis of the Exploratory C-Reactive Protein in Acute Myocardial Infarction-1 Study.
J Clin Med
; 11(21)2022 Oct 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-36362673
15.
The Resorbable Magnesium Scaffold Magmaris in Acute Coronary Syndrome: An Appraisal of Evidence and User Group Guidance.
Cardiovasc Revasc Med
; 39: 106-113, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34629285
16.
No Difference in 30-Day Outcome and Quality of Life in Transradial Versus Transfemoral Access - Results From the German Austrian ABSORB Registry (GABI-R).
Cardiovasc Revasc Med
; 40: 144-149, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34844868
17.
Successful Treatment of a 39-Year-Old COVID-19 Patient with Respiratory Failure by Selective C-Reactive Protein Apheresis.
Am J Case Rep
; 22: e932964, 2021 Aug 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34351878
18.
C-Reactive Protein Apheresis as Anti-inflammatory Therapy in Acute Myocardial Infarction: Results of the CAMI-1 Study.
Front Cardiovasc Med
; 8: 591714, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33778017
19.
Cardiac glycosides potently inhibit C-reactive protein synthesis in human hepatocytes.
Biochem Biophys Res Commun
; 394(1): 233-9, 2010 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-20206126
20.
Interferon beta-1b therapy in chronic viral dilated cardiomyopathy--is there a role for specific therapy?
J Card Fail
; 16(4): 348-56, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20350703